The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,765.00
Bid: 2,113.00
Ask: 1,681.00
Change: 4.00 (0.23%)
Spread: -432.00 (-20.445%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

Tue, 16th Jan 2024 09:14

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

JPMorgan cuts Rightmove to 'underweight' (neutral) - price target 493 (585) pence

----------

Goldman Sachs raises Rightmove price target to 667 (659) pence - 'neutral'

----------

JPMorgan cuts HSBC price target to 660 (690) pence - 'neutral'

----------

JPMorgan cuts Standard Chartered price target to 820 (990) pence - 'overweight'

----------

Jefferies cuts Standard Chartered price target to 1,050 (1,100) pence - 'buy'

----------

JPMorgan cuts NatWest price target to 260 (280) pence - 'overweight'

----------

JPMorgan cuts Barclays price target to 180 (190) pence - 'overweight'

----------

Jefferies raises Berkeley price target to 4,706 (4,572) pence - 'hold'

----------

Jefferies raises Barratt Developments price target to 583 (470) pence - 'hold'

----------

Peel Hunt cuts Taylor Wimpey to 'hold' (add) - price target 145 (125) pence

----------

Jefferies raises Taylor Wimpey price target to 172 (143) pence - 'buy'

----------

JPMorgan raises Taylor Wimpey price target to 101 (96) pence - 'neutral'

----------

Citigroup raises Beazley price target to 723 (680) pence - 'buy'

----------

Citigroup cuts Prudential price target to 1130 (1350) pence - 'buy'

----------

UBS cuts Rentokil Initial price target to 375 (460) pence - 'sell'

----------

Goldman Sachs raises Auto Trader group price target to 886 (863) pence - 'buy'

----------

Barclays cuts Croda International target to 5,000 (6,300) pence - 'equal weight'

----------

Goldman Sachs raises WPP price target to 870 (849) pence - 'neutral'

----------

Goldman Sachs raises Informa price target to 1,027 (1,019) pence - 'buy'

----------

Goldman Sachs raises Relx price target to 3,795 (3,405) pence - 'buy'

----------

Goldman Sachs raises Pearson price target to 1,319 (1,225) pence - 'buy'

----------

Berenberg cuts Rolls-Royce to 'sell' (hold) - price target 240 (100) pence

----------

Bernstein raises Convatec price target to 305 (285) pence - 'outperform'

----------

Morgan Stanley raises AstraZeneca price target to 13,400 (12,900) pence - 'overweight'

----------

UBS cuts AstraZeneca to 'sell' (buy) - price target 10,700 (13,000) pence

----------

Morgan Stanley raises GSK price target to 1730 (1535) pence - 'equal-weight'

----------

UBS raises GSK to 'buy' (sell) - price target 1,860 (1,310) pence

----------

Citigroup raises St James's Place price target to 667 (660) pence - 'neutral'

----------

Citigroup raises Phoenix price target to 509 (501) pence - 'neutral'

----------

Citigroup raises M&G price target to 223 (208) pence - 'neutral'

----------

Citigroup raises Legal & General price target to 254 (232) pence - 'neutral'

----------

Citigroup raises Aviva price target to 450 (422) pence - 'neutral'

----------

Deutsche Bank cuts Diageo price target to 2,450 (2,470) pence - 'sell'

----------

Goldman Sachs raises Experian price target to 4,250 (4,000) pence - 'buy'

----------

FTSE 250

----------

RBC starts Premier Foods with 'outperform' - price target 180 pence

----------

Citigroup raises Hiscox price target to 1,084 (1,032) pence - 'neutral'

----------

RBC cuts PageGroup price target to 550 (560) pence - 'outperform'

----------

Barclays raises Spire Healthcare price target to 315 (305) pence - 'overweight'

----------

Berenberg raises Direct Line to 'buy' (hold) - price target 195 (170) pence

----------

Jefferies raises Redrow price target to 774 (635) pence - 'buy'

----------

Jefferies raises Vistry price target to 1,023 (831) pence - 'hold'

----------

Citigroup cuts Drax to 'sell' (buy) - price target 437 (474) pence

----------

Barclays cuts Johnson Matthey target to 2,030 (2,100) pence - 'equal weight'

----------

Goldman Sachs cuts ITV to 'sell' (neutral) - price target 60 (67) pence

----------

Jefferies raises Persimmon to 'buy' (hold) - price target 1,706 (1,181) pence

----------

Jefferies cuts Crest Nicholson to 'hold' (buy) - price target 234 (331) pence

----------

Jefferies raises Bellway price target to 3,301 (2,827) pence - 'buy'

----------

Jefferies cuts Moneysupermarket.com to 'hold' (buy) - price target 265 (305) pence

----------

JPMorgan raises Ashmore price target to 185 (183) pence - 'underweight'

----------

SMALL CAP

----------

Numis cuts Wise to 'hold' (buy) - price target 950 pence

----------

Morgan Stanley raises Wise price target to 1,070 (1,050) pence - 'overweight'

----------

Goldman Sachs raises Wise price target to 1,250 (1,200) pence - 'buy'

----------

Goldman Sachs raises Wise price target to 1,250 (1,200) pence - 'buy'

----------

UBS cuts Card Factory price target to 107 (109) pence - 'neutral'

----------

investec cuts Reach to 'hold' (buy) - price target 70 (100) pence

----------

Peel Hunt raises Oxford Nanopore to 'reduce' (sell) - price target 155 pence

----------

Barclays raises Synthomer price target to 416 (187) pence - 'equal weight'

----------

JPMorgan cuts Bank of Ireland to 'underweight' (neutral) - price target 8 (10.80) EUR

----------

JPMorgan cuts AIB price target to 4.80 (5.80) EUR - 'overweight'

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.